Clinical Trial Update: A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase I imaging and pharmacodynamic trial of CS-1008 in metastatic colorectal cancer has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms

Drugs mentioned

• CS-1008

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Colorectal Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2019-09-23